Evidence map›Paper›PMID 21263238›Full record

ArticleThe American journal of surgical pathology2011

Molecular characteristics of mantle cell lymphoma presenting with clonal plasma cell component.

Carlo Visco, Sylvia Hoeller, Jeffrey T Malik, Zijun Y Xu-Monette, Michele L Wiggins, Jessica Liu, Warren G Sanger, Zhongfeng Liu, Julie Chang, Erik A Ranheim and 12 more

Open access · greenAbstract readMulticenter Study
In one paragraph

Article in The American journal of surgical pathology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.8field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. The pathologic diagnosis of mantle cell lymphoma.Histology and histopathology · 2021
    Review
  4. Article
  5. AL amyloidosis with a localized B cell neoplasia.Virchows Archiv : an international journal of pathology · 2019
    Article
  6. Article
  7. Review
  8. Plasma cell and terminal B-cell differentiation in mantle cell lymphoma mainly occur in the SOX11-negative subtype.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2015
    Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 9 institutions in 5 countries.

Carlo ViscoDepartment of Pathology, University of Wisconsin School of Medicine and Public Health, Madison, USA.
Sylvia Hoeller
Jeffrey T Malik
Zijun Y Xu-Monette
Michele L Wiggins
Jessica Liu
Warren G Sanger
Zhongfeng Liu
Julie Chang
Erik A Ranheim
Joel F Gradowski
Sergio Serrano
Huan-You Wang
Qingquan Liu
Sandeep Dave
Brian Olsen
Randy D Gascoyne
Elias Campo
Steven H Swerdlow
Wing C Chan
Alexander Tzankov
Ken H Young
University of Nebraska Medical Center · USUniversity Hospital of Basel · CHUniversity of Pittsburgh · USDuke University · USMcLaren Greater Lansing · USUniversitat Autònoma de Barcelona · ESUniversitat de Barcelona · ESUniversity of California, San Diego · USUniversity of Wisconsin–Madison · US

Funding

Molecular Signatures to Improve Diagnosis and Outcome PrU01CA114778 · NCI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI CHAN, WING C. · 2005 to 2009
$8.7M
PLANNING AND EVALUATIONP20CA103697 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI WEINDRUCH, RICHARD · 2003 to 2007
$3.0M
Convergence of MicroRNAs and p53 Signaling in Multiple Myeloma: Environmental CoR01CA138688 · NCI · UNIVERSITY OF LOUISVILLE · PI LI, YONG · 2009 to 2017
$2.9M
Deep Sequencing of Small Regulatory RNAs in Diffuse Large B cell LymphomaRC1CA146299 · NCI · SCRIPPS RESEARCH INSTITUTE, THE · PI XIAO, CHANGCHUN · 2009 to 2010
$1000k
NCI NIH HHS 1RC1CA146299NCI NIH HHS P20 CA103697NCI NIH HHS P20CA103697NCI NIH HHS R01 CA138688NCI NIH HHS R01CA138688NCI NIH HHS RC1 CA146299NCI NIH HHS U01 CA 114778NCI NIH HHS U01 CA114778
6 · The paper itself

Abstract

The normal counterparts of mantle cell lymphoma (MCL) are naive, quiescent B cells that have not been processed through the germinal center (GC). For this reason, although lymphomas arising from GC or post-GC B cells often exhibit plasmacytic differentiation, MCL rarely presents with plasmacytic features. Seven cases of MCL with a monotypic plasma cell (PC) population were collected from 6 centers and were studied by immunohistochemistry, fluorescence immunophenotyping and interphase cytogenetics as a tool for the investigation of neoplasms analysis, capillary gel electrophoresis, and restriction fragment length polymorphism of immunoglobulin heavy chain analysis of microdissections of each of the MCL and PC populations to assess their clonal relationship. The clinical presentation was rather unusual compared with typical MCL, with 2 cases arising from the extranodal soft tissues of the head. All MCL cases were morphologically and immunohistochemically typical, bearing the t(11;14)(q13;q32). In all cases, the PC population was clonal. In 5 of the 7 cases, the MCL and PC clones showed identical restriction fragments, indicating a common clonal origin of the neoplastic population. The 2 cases with clonal diversity denoted the coexistence of 2 different tumors in a composite lymphoma/PC neoplasm. Our findings suggest that MCL can present with a PC component that is often clonally related to the lymphoma, representing a rare but unique biological variant of this tumor.

Indexed as

Chromosomes, Human, Pair 11Chromosomes, Human, Pair 14AgedAged, 80 and overBiomarkers, TumorClone CellsDNA, NeoplasmFemaleHumansImmunoenzyme TechniquesImmunoglobulin Heavy ChainsImmunophenotypingIn Situ Hybridization, FluorescenceLymphoid TissueLymphoma, Mantle-CellMaleBiomarkers, TumorDNA, NeoplasmImmunoglobulin Heavy Chains

Identifiers

PMID21263238
PMCPMC3079277
OpenAlexW1986973952

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.